Search Orphan Drug Designations and Approvals
-
Generic Name: | alpha1 proteinase inhibitor (human) |
---|---|
Date Designated: | 01/29/2010 |
Orphan Designation: | Treatment of emphysema secondary to congenital alpha1-antitrypsin deficiency. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Grifols Therapeutics, Inc. 79 TW Alexander Drive Research Triangle Park, North Carolina 27709 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-